Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01HJZ
|
||||
| Former ID |
DNC010213
|
||||
| Drug Name |
N,N-dimethyl-2,2-diphenylethanamine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530331] | ||
| Formula |
C16H19N
|
||||
| Canonical SMILES |
CN(C)CC(C1=CC=CC=C1)C2=CC=CC=C2
|
||||
| InChI |
1S/C16H19N/c1-17(2)13-16(14-9-5-3-6-10-14)15-11-7-4-8-12-15/h3-12,16H,13H2,1-2H3
|
||||
| InChIKey |
UAUJDKBNVRSJBD-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [530331] | |
| Histamine H1 receptor | Target Info | Inhibitor | [530331] | ||
| WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| SIDS Susceptibility Pathways | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP58:Monoamine GPCRs | |||||
| IL-4 Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.